About DeltaVital
DeltaVital was a Healthcare company based in Goteborg (Sweden) founded in 2014. It develops novel risk markers for detecting arrhythmia in patients. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Medical Diagnostics and Cardiac Risk Markers. Its competitors include Imperative Care, Cardiac Insight, Topera, CardioComm Solutions and CoreMap and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
DeltaVital, based in Goteborg, focuses on providing healthcare solutions, advancing biotech innovations, medical diagnostics, and cardiac risk markers. Develops novel risk markers for detecting arrhythmia in patients. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Goteborg, Sweden
- SectorsHealthcare
- Website deltavital.eu
- Social X
Competitors of DeltaVital
DeltaVital has 10 listed competitors in our database, 9 of them funded. They include Imperative Care, Cardiac Insight, Topera, CardioComm Solutions and CoreMap, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imperativecare.com | 2015 | Campbell, United States | $496M | 90 | Access catheters for neurovascular stroke treatment are provided. | |
| cardiacinsightinc.com | 2008 | Bellevue, United States | $37.18M | 23 | Point-of-care cardiac diagnostics are provided for sports medicine. | |
| toperamedical.com | 2010 | Menlo Park, United States | $31.52M | – | Catheter-based electrophysiology mapping for atrial fibrillation treatment is offered. | |
| cardiocommsolutions.com | 1989 | Toronto, Canada | $372,710 | – | Software for ECG management and reporting is provided. | |
| coremapmedical.com | 2017 | Burlington, United States | $31.3M | – | Atrial fibrillation detection platform is provided for heart disorder management. | |
| wearlinq.com | 2019 | Stanford, United States | $12.28M | – | A wearable ECG device is provided for heart disorder detection. | |
| mindrhythm.com | 2019 | Los Altos, United States | $5M | – | Provider of a medical diagnostic medical device for stroke management | |
| baropace.com | 2019 | Ashland, United States | $940,000 | – | Smart wearable devices for cardiac health monitoring are developed. | |
| lifelenstech.com | 2014 | Warminster, United States | $24.57M | – | Developer of a device for cardiac health monitoring | |
| tianyihexin.com | 2014 | Nanjing, China | – | – | Diagnostic sensors and electronic chips are manufactured for various applications. |
Detailed competitors of DeltaVital
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as DeltaVital (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DeltaVital
DeltaVital was founded in 2014.
DeltaVital is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
DeltaVital, based in Goteborg, focuses on providing healthcare solutions, advancing biotech innovations, medical diagnostics, and cardiac risk markers. Develops novel risk markers for detecting arrhythmia in patients. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
DeltaVital's top competitors include Imperative Care, Cardiac Insight and Wearlinq.